DiaGenic Taps Ferrer InCode as Distributor | GenomeWeb

NEW YORK (GenomeWeb News) – Norwegian gene expression-based diagnostics company DiaGenic said today that it has signed up Ferrer InCode to distribute its Alzheimer's disease test in certain countries in Europe and Latin America.

Barcelona, Spain-based Ferrer InCode will distribute the ADtect test for early diagnosis of Alzheimer's disease in Germany, Belgium, France, the Netherlands, Italy, Spain, and Portugal, as well as in Latin American nations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.